Skip to main content
After obtaining a PSC request number via iLabs, samples may be dropped off at your convenience in Brinkhous-Bullit. The submission/pickup table is located just outside the elevators on the 9th floor, and the building is open M-F, 7am to 5pm. Please identify all items with submitter name, PI name and iLabs request number.

Please see the following ABRF authorship guidelines related to Core Facility Staff

Any service provided by the Pathology Services Core included in a publication should acknowledge the contribution of the core facility and our staff. Proper acknowledgment of our facility enables us to obtain financial and other support so we may continue to provide essential services. Please send a link of newly published work to the Facility Director.


If staff do not meet the requirements for authorship, please use the following suggested excerpts:

We thank SPECIFIC STAFF MEMBERS in the Pathology Services Core for expert technical assistance with SPECIFIC SERVICES. The PSC is supported in part by an NCI Center Core Support Grant (P30CA016086).
Histopathology/Digital Pathology was performed by the Pathology Services Core at the University of North Carolina-Chapel Hill, which is supported in part by an NCI Center Core Support Grant (P30CA016086)

PSC Staff

  1. Gabriela De La Cruz
  2. Bentley Midkiff
  3. Yongjuan Xia
  4. Albert Wielgus
  5. Lauren Ralph
  6. Mia Evangelista
  7. Ling Wang
  8. Cassie Pham
  9. Edison Floyd
  10. Nicholas Pankow

PSC Publications

The following is a list of publications by clients of the UNC Pathology Services Core, which contributed to several projects. PSC personnel who are listed as co-authors are indicated in bold.


  1. Xu, J., et al., Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene. JCI Insight, 2021. 6(1): p. 139813.
  2. Walsh, T., et al., Inherited predisposition to breast cancer in the Carolina Breast Cancer Study. NPJ Breast Cancer, 2021. 7(1): p. 6.
  3. Wallace, K., et al., Preinvasive Colorectal Lesions of African Americans Display an Immunosuppressive Signature Compared to Caucasian Americans. Front Oncol, 2021. 11(659036): p. 659036.
  4. Walens, A., et al., Protein-based immune profiles of basal-like vs. luminal breast cancers. Laboratory Investigation, 2021. 23(10): p. 020-00506.
  5. Wahl, A., et al., SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature, 2021. 591(7850): p. 451-457.
  6. Trembath, D.G., et al., Melanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases. Melanoma Research, 2021. 31(3): p. 264-267.
  7. Nichols, H.B., et al., Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium. Breast Cancer Research and Treatment, 2021. 185(2): p. 469-478.
  8. Nguyen, G.N., et al., A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Nature Biotechnology, 2021. 39(1): p. 47-55.
  9. Musicant, A.M., et al., CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition. Cell Rep, 2021. 34(8): p. 108768.
  10. Moschos, S.J., et al., Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922). Melanoma Research, 2021. 31(2): p. 162-172.
  11. Jewells, V.L., et al., Assessment of (18)F-PBR-111 in the Cuprizone Mouse Model of Multiple Sclerosis. Diagnostics (Basel), 2021. 11(5): p. 786.
  12. Copp, M.E., et al., The combination of mitogenic stimulation and DNA damage induces chondrocyte senescence. Osteoarthritis and Cartilage, 2021. 29(3): p. 402-412.
  13. Benefield, H.C., et al., Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium. Cancer Epidemiology Biomarkers & Prevention, 2021. 30(1): p. 71-79.
  14. Benefield, H.C., et al., Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features. JNCI Cancer Spectr, 2021. 5(1): p. pkaa072.
  15. Wang, J., et al., MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair. Nanomedicine, 2020. 27: p. 102201.
  16. Trembath, D.G., et al., Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases. Front Oncol, 2020. 10(2899): p. 604213.
  17. Spencer, J.C., et al., Employment Changes Following Breast Cancer Diagnosis: The Effects of Race and Place. Journal of the National Cancer Institute, 2020. 112(6): p. 647-650.
  18. Sparkenbaugh, E.M., et al., High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease. J Thromb Haemost, 2020. 18(9): p. 2329-2340.
  19. Sheahan, T.P., et al., Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun, 2020. 11(1): p. 222.
  20. Rashid, N.U., et al., Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer. Clin Cancer Res, 2020. 26(1): p. 82-92.
  21. Parada, H., Jr., et al., Plasma levels of polychlorinated biphenyls (PCBs) and breast cancer mortality: The Carolina Breast Cancer Study. Int J Hyg Environ Health, 2020. 227(113522): p. 113522.
  22. Nixon, C.C., et al., Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature, 2020. 578(7793): p. 160-165.
  23. Lipner, M.B., et al., Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. JCI Insight, 2020. 5(8).
  24. Kardos, J., et al., Development and validation of a NanoString BASE47 bladder cancer gene classifier. PLoS One, 2020. 15(12): p. e0243935.
  25. Jiang, H., et al., Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Journal of Clinical Investigation, 2020. 130(9): p. 4704-4709.
  26. Hu, P.Q., et al., Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN. Journal of the American Society of Nephrology, 2020. 31(2): p. 297-307.
  27. Harrison, E.B., et al., A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking. Cancer Research, 2020. 80(22): p. 4972-4985.
  28. Emerson, M.A., et al., Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008-2013. Cancer Causes and Control, 2020. 31(3): p. 221-230.
  29. Emerson, M.A., et al., Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. Cancer, 2020. 126(22): p. 4957-4966.
  30. Eason, A.B., et al., DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma. PLoS One, 2020. 15(5): p. e0233116.
  31. Bhattacharya, A., et al., An approach for normalization and quality control for NanoString RNA expression data. Brief Bioinform, 2020. 13(10).
  32. Bhattacharya, A., et al., A framework for transcriptome-wide association studies in breast cancer in diverse study populations. Genome Biol, 2020. 21(1): p. 42.
  33. Bhatt, A.P., et al., Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci U S A, 2020. 117(13): p. 7374-7381.
  34. Benefield, H.C., et al., Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women. Journal of the National Cancer Institute, 2020. 112(7): p. 728-736.
  35. Au, K.M., A.Z. Wang, and S.I. Park, Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin’s lymphoma. Sci Adv, 2020. 6(14): p. eaaz9798.
  36. Au, K.M., S.I. Park, and A.Z. Wang, Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy. Sci Adv, 2020. 6(27): p. eaba8564.
  37. Aldaregia, J., et al., Erbb4 Is Required for Cerebellar Developmentand Malignant Phenotype of Medulloblastoma. Cancers (Basel), 2020. 12(4).
  38. Martinez, D. R., Schäfer, A., Gobeil, S., Dapeng, L., De la Cruz, G., Parks, R., Lu, X., Barr, M., Stalls, V., Janowska, K., Beaudoin, E., Manne, K., Mansouri, K., Edwards, R.J., Cronin, K., Yount, B., Anasti, K., Montgomery, S.A., Tang, J., Golding, H., Shen, S., Zhou, T., Kwong, P.D., Graham, B.S., Mascola, J.R., Montefori, D.C., Alam, S. M., Sempowski, G.D., Wiehe, K., Saunders, K.O., Acharya, P., Haynes, B.F., Baric, R.S. A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice. Sci. Translat. Med. 2021; doi: 101126/scitranslmed.abj7125. PMID: 34726473
  39. Martinez, D. R., Schäfer, A., Leist, S., De la Cruz, G., West, A., Atochina-Vasserman, E., Lindesmith, L.C., Pardi, N., Parks, R., Barr, M., Li., D., Yount, B., Saunders, K., Weissman, D., Haynes, B., Montgomery, S.A., Baric, R.S.. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 2021. Jun22;eabi45016 DOI:10.1126/science.abi4506 PMID: 34224046
  40. Martinez, D. R., Schäfer, A., Leist, S.R., Li., D., Gully, K., Yount, B., Feng, J.Y., Bunyan, E., Porter, D.P., Cihlar, T., Montgomery, S.A., Haynes, B.F., Baric, R.S., Nussenzweig, M.C., Sheahan, T.P. Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice. Cell Rep. 2021. 36(4):109450. PMCID: PMC8270748
  41. Wahl, A., Gralinski, L., Johnson, C.E, Yao, W., Kovarova, M., Dinnon, K.H., Liu, H., Madden, V.J., Krystek, H.M., De, C., White, K.K., Gully, K., Schäfer, A., Zaman, T., Leist, S.R., Grant, P.O., Bluemling, G.R., Kolykhalov, A.A., Natchus, M.G., Askin, F.B, Painter, G., Browne, E.P., Jones, C.D., Pickles, R.J, Baric, R.S., Garcia, V.J.  SARS-CoV-2 infection is effictively treated and prevented by EIDD-2801. Nature. 2021. 591(7850):451-457. PMCID: PMC7979515


  1. Wang J, Lee CJ, Deci MB, Jasiewicz N, Verma A, Canty JM, et al. MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair. Nanomedicine : nanotechnology, biology, and medicine. 2020:102201. Epub 2020/04/12. doi: 10.1016/j.nano.2020.102201. PubMed PMID: 32278100.
  2. Dinnon, K. H., Leist, S. R., Schäfer, A., Edwards, C. E., Martinez, D. R., Montgomery, S. A., West, A., Yount, B. L., Hou, Y. J., Adams, L. E., Gully, K. L., Brown, A. J., Huang, E., Bryant, M. D., Choong, I. C., Glenn, J. S., Gralinski, L. E., Sheahan, T. P., & Baric, R. S. (2020). A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature, 586(7830), 560–566.
  3. Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., Spahn, J. E., Bauer, L., Sellers, S., Porter, D., Feng, J. Y., Cihlar, T., Jordan, R., Denison, M. R., & Baric, R. S. (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1).
  4. Leist, S. R., Dinnon, K. H., Schäfer, A., Tse, L. V., Okuda, K., Hou, Y. J., West, A., Edwards, C. E., Sanders, W., Fritch, E. J., Gully, K. L., Scobey, T., Brown, A. J., Sheahan, T. P., Moorman, N. J., Boucher, R. C., Gralinski, L. E., Montgomery, S. A., & Baric, R. S. (2020). A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell, 183(4).


  1. Allen Jt, Gyorke CE, Tripathy MK, Zhang Y, Lovett A, Montgomery SA, et al. Caspase-11 Contributes to Oviduct Pathology during Genital Chlamydia Infection in Mice. Infect Immun. 2019;87(8). Epub 2019/06/05. doi: 10.1128/iai.00262-19. PubMed PMID: 31160363; PubMed Central PMCID: PMC6652777.
  2. Willis MS, Parry TL, Brown DI, Mota RI, Huang W, Beak JY, et al. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1. Circulation Heart failure. 2019;12(3):e005234. Epub 2019/03/16. doi: 10.1161/CIRCHEARTFAILURE.118.005234. PubMed PMID: 30871347; PubMed Central PMCID: PMC6422170.
  3. Miret JJ, Kirschmeier P, Koyama S, Zhu M, Li YY, Naito Y, et al. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity. Journal for immunotherapy of cancer. 2019;7(1):32. Epub 2019/02/08. doi: 10.1186/s40425-019-0504-5. PubMed PMID: 30728077; PubMed Central PMCID: PMC6366094.
  4. Kelleher AM, Behura SK, Burns GW, Young SL, DeMayo FJ, Spencer TE. Integrative analysis of the forkhead box A2 (FOXA2) cistrome for the human endometrium. FASEB J. 2019;33(7):8543-54. Epub 2019/04/06. doi: 10.1096/fj.201900013R. PubMed PMID: 30951376; PubMed Central PMCID: PMC6593875.
  5. Flores-Hidalgo A, Murrah V, Fedoriw Y, Padilla RJ. Relationship of infiltrating intraepithelial T lymphocytes in the diagnosis of oral lichen planus versus oral epithelial dysplasia: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2019;127(6):e123-e35. Epub 2019/04/01. doi: 10.1016/j.oooo.2019.02.004. PubMed PMID: 30928328.
  6. Eluri S, Selitsky SR, Perjar I, Hollyfield J, Betancourt R, Randall C, et al. Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019;17(6):1081-8 e2. Epub 2018/09/15. doi: 10.1016/j.cgh.2018.09.005. PubMed PMID: 30213583; PubMed Central PMCID: PMC6409124.
  7. Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, et al. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Gastroenterology. 2019;157(1):65-73 e5. Epub 2019/03/16. doi: 10.1053/j.gastro.2019.03.014. PubMed PMID: 30872104; PubMed Central PMCID: PMC6581596.
  8. Beak JY, Kang HS, Huang W, Myers PH, Bowles DE, Jetten AM, et al. The nuclear receptor RORalpha protects against angiotensin II-induced cardiac hypertrophy and heart failure. Am J Physiol Heart Circ Physiol. 2019;316(1):H186-H200. Epub 2018/11/06. doi: 10.1152/ajpheart.00531.2018. PubMed PMID: 30387679; PubMed Central PMCID: PMC6383360.
  9. Azam SH, Porrello A, Harrison EB, Leslie PL, Liu X, Waugh TA, et al. Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis. Oncogene. 2019;38(26):5191-210. Epub 2019/03/29. doi: 10.1038/s41388-019-0786-6. PubMed PMID: 30918328; PubMed Central PMCID: PMC6597267.
  10. Carper, M. B., Troutman, S., Wagner, B. L., Byrd, K. M., Selitsky, S. R., Parag-Sharma, K., Henry, E. C., Li, W., Parker, J. S., Montgomery, S. A., Cleveland, J. L., Williams, S. E., Kissil, J. L., Hayes, D. N., & Amelio, A. L. (2019). An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma. Cell Reports, 29(6).


  1. Zheng X, O’Connell CM, Zhong W, Nagarajan UM, Tripathy M, Lee D, et al. Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease. J Immunol. 2018;200(8):2941-56. Epub 2018/03/14. doi: 10.4049/jimmunol.1701658. PubMed PMID: 29531169; PubMed Central PMCID: PMC5893373.
  2. Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018;361(6399):290-5. Epub 2018/07/22. doi: 10.1126/science.aap8411. PubMed PMID: 30026228; PubMed Central PMCID: PMC6154478.
  3. Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, et al. MerTK as a therapeutic target in glioblastoma. Neuro Oncol. 2018;20(1):92-102. Epub 2017/06/13. doi: 10.1093/neuonc/nox111. PubMed PMID: 28605477; PubMed Central PMCID: PMC5761530.
  4. Williams LA, Butler EN, Sun X, Allott EH, Cohen SM, Fuller AM, et al. TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases. NPJ breast cancer. 2018;4:13. Epub 2018/06/29. doi: 10.1038/s41523-018-0067-5. PubMed PMID: 29951581; PubMed Central PMCID: PMC6018637 Genomics and filed a patent on the PAM50 intrinsic breast cancer subtyping assay.
  5. Wang X, Li X, Wang T, Wu SP, Jeong JW, Kim TH, et al. SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh. Nature communications. 2018;9(1):4421. Epub 2018/10/26. doi: 10.1038/s41467-018-06652-w. PubMed PMID: 30356064; PubMed Central PMCID: PMC6200785.
  6. Vasquez YM, Wang X, Wetendorf M, Franco HL, Mo Q, Wang T, et al. FOXO1 regulates uterine epithelial integrity and progesterone receptor expression critical for embryo implantation. PLoS genetics. 2018;14(11):e1007787. Epub 2018/11/20. doi: 10.1371/journal.pgen.1007787. PubMed PMID: 30452456; PubMed Central PMCID: PMC6277115.
  7. Troester MA, Sun X, Allott EH, Geradts J, Cohen SM, Tse CK, et al. Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study. J Natl Cancer Inst. 2018;110(2):djx135. Epub 2017/09/02. doi: 10.1093/jnci/djx135. PubMed PMID: 28859290; PubMed Central PMCID: PMC6059138.
  8. Torphy RJ, Wang Z, True-Yasaki A, Volmar KE, Rashid N, Yeh B, et al. Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma. JCO Precis Oncol. 2018;2018. Epub 2018/12/07. doi: 10.1200/PO.17.00121. PubMed PMID: 30506016; PubMed Central PMCID: PMC6262879.
  9. Tappata M, Eluri S, Perjar I, Hollyfield J, Betancourt R, Randall C, et al. Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy. 2018;73(10):2088-92. Epub 2018/06/24. doi: 10.1111/all.13530. PubMed PMID: 29935026; PubMed Central PMCID: PMC6207454.
  10. Stepp WH, Farquhar D, Sheth S, Mazul A, Mamdani M, Hackman TG, et al. RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status. JAMA Otolaryngology– Head & Neck Surgery. 2018;144(11):967-75. Epub 2018/05/02. doi: 10.1001/jamaoto.2018.0602. PubMed PMID: 29710215; PubMed Central PMCID: PMC6193859.
  11. Porrello A, Leslie PL, Harrison EB, Gorentla BK, Kattula S, Ghosh SK, et al. Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nature communications. 2018;9(1):1988. Epub 2018/05/20. doi: 10.1038/s41467-018-04355-w. PubMed PMID: 29777108; PubMed Central PMCID: PMC5959879.
  12. Okolie O, Irvin DM, Bago JR, Sheets K, Satterlee A, Carey-Ewend AG, et al. Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection. PloS one. 2018;13(7):e0198596. Epub 2018/07/11. doi: 10.1371/journal.pone.0198596. PubMed PMID: 29990322; PubMed Central PMCID: PMC6038981 adherence to PLoS ONE policies on sharing data and materials.
  13. Mirlekar B, Michaud D, Searcy R, Greene K, Pylayeva-Gupta Y. IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. Cancer immunology research. 2018;6(9):1014-24. Epub 2018/07/08. doi: 10.1158/2326-6066.CIR-17-0710. PubMed PMID: 29980536; PubMed Central PMCID: PMC6125203.
  14. Keith BP, Barrow JB, Toyonaga T, Kazgan N, O’Connor MH, Shah ND, et al. Colonic epithelial miR-31 associates with the development of Crohn’s phenotypes. JCI insight. 2018;3(19):122788. Epub 2018/10/05. doi: 10.1172/jci.insight.122788. PubMed PMID: 30282822; PubMed Central PMCID: PMC6237459.
  15. Keith BP, Barrow JB, Toyonaga T, Kazgan N, O’Connor MH, Shah ND, et al. Colonic epithelial miR-31 associates with the development of Crohn’s phenotypes. JCI insight. 2018;3(19). Epub 2018/10/05. doi: 10.1172/jci.insight.122788. PubMed PMID: 30282822; PubMed Central PMCID: PMC6237459.
  16. Joseph R CK, Bortone DS, Vincent BG, Yeh JJ, and McRee AJ. Basal-like Pancreatic Adenocarcinoma (PDAC) Subtypes Demonstrate Increased Expression of Immune Genes and a Signature of PD-1 Inhibition Resistance. 2018.
  17. Dellon ES, Selitsky SR, Genta RM, Lash RH, Parker JS. Gene expression-phenotype associations in adults with eosinophilic esophagitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2018;50(8):804-11. Epub 2018/04/10. doi: 10.1016/j.dld.2018.03.021. PubMed PMID: 29628359; PubMed Central PMCID: PMC6059985.
  18. Davis RB, Pahl K, Datto NC, Smith SV, Shawber C, Caron KM, et al. Notch signaling pathway is a potential therapeutic target for extracranial vascular malformations. Scientific reports. 2018;8(1):17987. Epub 2018/12/24. doi: 10.1038/s41598-018-36628-1. PubMed PMID: 30573741; PubMed Central PMCID: PMC6302123.
  19. Chang HJ, Yoo JY, Kim TH, Fazleabas AT, Young SL, Lessey BA, et al. Overexpression of Four Joint Box-1 Protein (FJX1) in Eutopic Endometrium From Women With Endometriosis. Reproductive sciences (Thousand Oaks, Calif). 2018;25(2):207-13. Epub 2017/07/05. doi: 10.1177/1933719117716780. PubMed PMID: 28673206; PubMed Central PMCID: PMC5933103.
  20. Camargo MC, Sivins A, Isajevs S, Folkmanis V, Rudzite D, Gulley ML, et al. Associations of Epstein-Barr Virus-Positive Gastric Adenocarcinoma with Circulating Mediators of Inflammation and Immune Response. Cancers. 2018;10(9). Epub 2018/08/26. doi: 10.3390/cancers10090284. PubMed PMID: 30142953; PubMed Central PMCID: PMC6162799.
  21. Busch EL, Don PK, Chu H, Richardson DB, Keku TO, Eberhard DA, et al. Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC cancer. 2018;18(1):82. Epub 2018/01/18. doi: 10.1186/s12885-017-3964-3. PubMed PMID: 29338703; PubMed Central PMCID: PMC5769498.
  22. Allott EH, Geradts J, Cohen SM, Khoury T, Zirpoli GR, Bshara W, et al. Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res. 2018;20(1):12. Epub 2018/02/08. doi: 10.1186/s13058-018-0939-5. PubMed PMID: 29409530; PubMed Central PMCID: PMC5801839.
  23. Du, H., Hirabayashi, K., Ahn, S., Kren, N. P., Montgomery, S. A., Wang, X., Tiruthani, K., Mirlekar, R., Michaud, D., Greene, K., Herrera, S. G., Sun, C., Chen, Y., Xu, Y., Ma, X., Ferrone, C. R., Pylayeva-Gupta, Y., Yeh, J. J., Liu, R., … Dotti, G. (2018). Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 Via Chimeric Antigen Receptor T Cells. SSRN Electronic Journal.


  1. Young SL, Savaris RF, Lessey BA, Sharkey AM, Balthazar U, Zaino RJ, et al. Effect of randomized serum progesterone concentration on secretory endometrial histologic development and gene expression. Hum Reprod. 2017;32(9):1903-14. Epub 2017/09/01. doi: 10.1093/humrep/dex252. PubMed PMID: 28854727; PubMed Central PMCID: PMC5850604.
  2. Yoo JY, Kim TH, Fazleabas AT, Palomino WA, Ahn SH, Tayade C, et al. KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance. Scientific reports. 2017;7(1):6765. Epub 2017/07/30. doi: 10.1038/s41598-017-04577-w. PubMed PMID: 28754906; PubMed Central PMCID: PMC5533722.
  3. Westmoreland KD, Stanley CC, Montgomery ND, Kaimila B, Kasonkanji E, El-Mallawany NK, et al. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatric blood & cancer. 2017;64(5). Epub 2016/10/27. doi: 10.1002/pbc.26302. PubMed PMID: 27781380; PubMed Central PMCID: PMC5529120.
  4. Westmoreland KD, Montgomery ND, Stanley CC, El-Mallawany NK, Wasswa P, van der Gronde T, et al. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. Int J Cancer. 2017;140(11):2509-16. Epub 2017/03/08. doi: 10.1002/ijc.30682. PubMed PMID: 28268254; PubMed Central PMCID: PMC5386821.
  5. Wang P, Wander CM, Yuan CX, Bereman MS, Cohen TJ. Acetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program. Nature communications. 2017;8(1):82. Epub 2017/07/21. doi: 10.1038/s41467-017-00088-4. PubMed PMID: 28724966; PubMed Central PMCID: PMC5517419.
  6. Vitucci M, Irvin DM, McNeill RS, Schmid RS, Simon JM, Dhruv HD, et al. Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma. Neuro Oncol. 2017;19(9):1237-47. Epub 2017/04/12. doi: 10.1093/neuonc/nox050. PubMed PMID: 28398584; PubMed Central PMCID: PMC5570221.
  7. Vick SC, Taylor NA, Iglesia MD, Brickey WJ, Carey LA, Midkiff BR, et al. Regulatory T cell recruitment limits the effectiveness of checkpoint inhibition for claudin-low breast cancer. Cancer Res. 2017;77(13 Suppl):abstract 568. doi: 10.1158/1538-7445.AM2017-568. PubMed PMID: ISI:000442496702021.
  8. Van Swearingen AED, Sambade MJ, Siegel MB, Sud S, McNeill RS, Bevill SM, et al. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer. Neuro Oncol. 2017;19(11):1481-93. Epub 2017/05/10. doi: 10.1093/neuonc/nox052. PubMed PMID: 28486691; PubMed Central PMCID: PMC5737524.
  9. Troester MA, Sun X, Allott EH, Kit CK, Thorne L, Mathews M, et al. Race and age differences in PAM50 biomarker status in the Carolina breast cancer study. Cancer Res. 2017;77. doi: 10.1158/1538-7445.SABCS16-PD8-01. PubMed PMID: ISI:000397999002395.
  11. Tech K, Tikunov AP, Farooq H, Morrissy AS, Meidinger J, Fish T, et al. Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation. Cancer Res. 2017;77(12):3217-30. Epub 2017/05/19. doi: 10.1158/0008-5472.CAN-16-3304. PubMed PMID: 28515149; PubMed Central PMCID: PMC5497486.
  12. Satterlee AB, Rojas JD, Dayton PA, Huang L. Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy. Theranostics. 2017;7(2):253-69. Epub 2017/01/04. doi: 10.7150/thno.16681. PubMed PMID: 28042332; PubMed Central PMCID: PMC5197062.
  13. Satterlee AB, Attayek P, Midkiff B, Huang L. A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility study. Radiat Oncol. 2017;12(1):54. Epub 2017/03/18. doi: 10.1186/s13014-017-0794-z. PubMed PMID: 28302144; PubMed Central PMCID: PMC5356254.
  14. Rusin S, Covey S, Perjar I, Hollyfield J, Speck O, Woodward K, et al. Determination of esophageal eosinophil counts and other histologic features of eosinophilic esophagitis by pathology trainees is highly accurate. Hum Pathol. 2017;62:50-5. Epub 2017/01/04. doi: 10.1016/j.humpath.2016.12.017. PubMed PMID: 28041975; PubMed Central PMCID: PMC5392430.
  15. Ren NSX, Ji M, Tokar EJ, Busch EL, Xu X, Lewis D, et al. Haploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development. Curr Biol. 2017;27(4):483-94. Epub 2017/02/07. doi: 10.1016/j.cub.2016.12.047. PubMed PMID: 28162896; PubMed Central PMCID: PMC5319916.
  16. Prince G, Deal AM, Mckee MJ, Trembath DG, Keith K, Ramirez J, et al. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases. J Clin Oncol. 2017;35(15_suppl):2072-. doi: 10.1200/Jco.2017.35.15_Suppl.2072. PubMed PMID: ISI:000411895704043.
  17. Perry JL, Reuter KG, Luft JC, Pecot CV, Zamboni W, DeSimone JM. Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location. Nano letters. 2017;17(5):2879-86. Epub 2017/03/14. doi: 10.1021/acs.nanolett.7b00021. PubMed PMID: 28287740; PubMed Central PMCID: PMC5708115.
  18. Moschos SJ, Eroglu Z, Gaughan EM, Medina TM, Wang P, Dees EC, et al. NCI 9922: Phase 2 study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM). J Clin Oncol. 2017;35(15_suppl):TPS9592-TPS. doi: 10.1200/Jco.2017.35.15_Suppl.Tps9592. PubMed PMID: ISI:000411932204047.
  19. Mitchell JK, Midkiff BR, Israelow B, Evans MJ, Lanford RE, Walker CM, et al. Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R. mBio. 2017;8(2). Epub 2017/04/27. doi: 10.1128/mBio.00121-17. PubMed PMID: 28442604; PubMed Central PMCID: PMC5405228.
  20. McNeill RS, Canoutas DA, Stuhlmiller TJ, Dhruv HD, Irvin DM, Bash RE, et al. Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma. Neuro Oncol. 2017;19(11):1469-80. Epub 2017/04/06. doi: 10.1093/neuonc/nox044. PubMed PMID: 28379424; PubMed Central PMCID: PMC5737415.
  21. Malinen MM AI, Beaudoin JJ, Brouwer KL. Bile Acid and Steroid Transporter OSTα/β is Over-Expressed in Liver from Patients With Non-alcoholic Steatohepatitis (NASH) and Primary Biliary Cirrhosis (PBC), and Modulated by Drugs Using a Novel In Vitro Cell System. Hepatology. 2017;TBA(AASLD Liver Meeting).
  22. Lucas AT, White TF, Deal AM, Herity LB, Song G, Santos CM, et al. Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models. Nanomedicine : nanotechnology, biology, and medicine. 2017;13(2):471-82. Epub 2016/10/18. doi: 10.1016/j.nano.2016.09.015. PubMed PMID: 27720926.
  23. Leung JY, Wilson HL, Voltzke KJ, Williams LA, Lee HJ, Wobker SE, et al. Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis. Mol Cell Biol. 2017;37(12). Epub 2017/03/23. doi: 10.1128/MCB.00565-16. PubMed PMID: 28320873; PubMed Central PMCID: PMC5452723.
  24. Khoury T, Zirpoli G, Cohen SM, Geradts J, Omilian A, Davis W, et al. Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods. Am J Clin Pathol. 2017;148(2):108-18. Epub 2017/09/14. doi: 10.1093/ajcp/aqx053. PubMed PMID: 28898983; PubMed Central PMCID: PMC5848430.
  25. Kardos J, Wobker SE, Woods ME, Nielsen ME, Smith AB, Wallen EM, et al. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype. JCO Precision Oncology. 2017;1(1):1-12. doi: 10.1200/Po.17.00027. PubMed PMID: ISI:000462058200037.
  26. Irvin DM, McNeill RS, Bash RE, Miller CR. Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models. Brain Pathol. 2017;27(1):36-50. Epub 2016/01/15. doi: 10.1111/bpa.12348. PubMed PMID: 26762242; PubMed Central PMCID: PMC5322824.
  27. Hisada Y, Ay C, Auriemma AC, Cooley BC, Mackman N. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size. Journal of thrombosis and haemostasis : JTH. 2017;15(11):2208-17. Epub 2017/08/24. doi: 10.1111/jth.13809. PubMed PMID: 28834179.
  28. Greene K ES, Meyers MO, Gulley ML. Robust Mutation Profiles in Cancer Biopsies and Resections. Journal of Molecular Diagnostics. 2017( Abstracts of the 1st Global Congress on Molecular Pathology):s1525-s78.
  29. Glaser SL, Canchola AJ, Keegan TH, Clarke CA, Longacre TA, Gulley ML. Variation in risk and outcomes of Epstein-Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study. Cancer Causes Control. 2017;28(4):273-87. Epub 2017/02/24. doi: 10.1007/s10552-017-0865-3. PubMed PMID: 28229344.
  30. Dellon ES, Veerappan R, Selitsky SR, Parker JS, Higgins LL, Beitia R, et al. A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults. Clinical and translational gastroenterology. 2017;8(2):e74. Epub 2017/02/10. doi: 10.1038/ctg.2017.2. PubMed PMID: 28181994; PubMed Central PMCID: PMC5387749.
  31. Dant TA, Lin KL, Bruce DW, Montgomery SA, Kolupaev OV, Bommiasamy H, et al. T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD. Blood. 2017;130(3):348-59. Epub 2017/05/28. doi: 10.1182/blood-2016-08-734244. PubMed PMID: 28550042; PubMed Central PMCID: PMC5520467.
  32. Chollet-Hinton L, Olshan AF, Nichols HB, Anders CK, Lund JL, Allott EH, et al. Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1722-9. Epub 2017/09/15. doi: 10.1158/1055-9965.EPI-17-0450. PubMed PMID: 28903991; PubMed Central PMCID: PMC5903207.
  33. Camargo MC SA, Isajevs S, Rudzite D, Gulley M, Offerhaus GJ, Leja M, Rabkin CS. Associations of Epstein-Barr virus (EBV)-positive gastric cancer with circulating mediators of inflammation and immune response. AACR. 2017;AACR2017 Proceedings:1085-6.
  34. Beak J, Huang W, Parker JS, Hicks ST, Patterson C, Simpson PC, et al. An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity. JACC Basic to translational science. 2017;2(1):39-53. Epub 2017/03/14. doi: 10.1016/j.jacbts.2016.10.006. PubMed PMID: 28286875; PubMed Central PMCID: PMC5343290.
  35. Bazyar S, Inscoe CR, Benefield T, Zhang L, Lu J, Zhou O, et al. Neurocognitive sparing of desktop microbeam irradiation. Radiat Oncol. 2017;12(1):127. Epub 2017/08/13. doi: 10.1186/s13014-017-0864-2. PubMed PMID: 28800740; PubMed Central PMCID: PMC5554005.
  36. Allott EH, Macias E, Sanders S, Knudsen BS, Thomas GV, Hursting SD, et al. Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model. Prostate cancer and prostatic diseases. 2017;20(2):165-71. Epub 2017/03/01. doi: 10.1038/pcan.2016.73. PubMed PMID: 28244492; PubMed Central PMCID: PMC5429178.


  1. Zhu H, Aryal DK, Olsen RH, Urban DJ, Swearingen A, Forbes S, et al. Cre-dependent DREADD (Designer Receptors Exclusively Activated by Designer Drugs) mice. Genesis. 2016;54(8):439-46. Epub 2016/05/20. doi: 10.1002/dvg.22949. PubMed PMID: 27194399; PubMed Central PMCID: PMC4990490.
  2. Zhang L, Han J, Jackson AL, Clark LN, Kilgore J, Guo H, et al. NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo. Journal of hematology & oncology. 2016;9(1):91. Epub 2016/09/23. doi: 10.1186/s13045-016-0325-7. PubMed PMID: 27655410; PubMed Central PMCID: PMC5031332.
  3. Yuan H, Frank JE, Merrill JR, Hillesheim DA, Khachaturian MH, Anzellotti AI. Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO). Current radiopharmaceuticals. 2016;9(3):235-43. Epub 2016/08/27. doi: 10.2174/1874471009666160725100940. PubMed PMID: 27562785.
  4. Wu Jing LNH, Ryan E. Bash, Stephanie M. Cohen, Allison Schorzman, William Zamboni, Xiaodong Wang, Stephen V. Frye, Matthew G. Ewend, Erik P. Sulman, Mark R. Gilbert, H. Shelton Earp and C. Ryan Miller*. MerTK as a therapeutic target in glioblastoma. 2016.
  5. Wells MA, Vendrov KC, Edin ML, Ferslew BC, Zha W, Nguyen BK, et al. Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis. Prostaglandins & other lipid mediators. 2016;125:19-29. Epub 2016/07/13. doi: 10.1016/j.prostaglandins.2016.07.002. PubMed PMID: 27401401; PubMed Central PMCID: PMC5035202.
  6. Treece AL, Duncan DL, Tang W, Elmore S, Morgan DR, Dominguez RL, et al. Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns. Lab Invest. 2016;96(6):661-71. Epub 2016/03/08. doi: 10.1038/labinvest.2016.33. PubMed PMID: 26950485; PubMed Central PMCID: PMC5767475.
  7. Taylor NJ, Nikolaishvili-Feinberg N, Midkiff BR, Conway K, Millikan RC, Geradts J. Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas. Appl Immunohistochem Mol Morphol. 2016;24(6):398-404. Epub 2015/07/23. doi: 10.1097/PAI.0000000000000207. PubMed PMID: 26200835; PubMed Central PMCID: PMC4716889.
  8. Swahari V, Nakamura A, Baran-Gale J, Garcia I, Crowther AJ, Sons R, et al. Essential Function of Dicer in Resolving DNA Damage in the Rapidly Dividing Cells of the Developing and Malignant Cerebellum. Cell Rep. 2016;14(2):216-24. Epub 2016/01/11. doi: 10.1016/j.celrep.2015.12.037. PubMed PMID: 26748703; PubMed Central PMCID: PMC4716786.
  9. Suri A, Sheng X, Schuler KM, Zhong Y, Han X, Jones HM, et al. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer. Oncotarget. 2016;7(26):39582-94. Epub 2016/10/27. doi: 10.18632/oncotarget.8659. PubMed PMID: 27074576; PubMed Central PMCID: PMC5129955.
  10. Suen AA, Jefferson WN, Wood CE, Padilla-Banks E, Bae-Jump VL, Williams CJ. SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer. Mol Cancer Res. 2016;14(9):849-58. Epub 2016/06/05. doi: 10.1158/1541-7786.MCR-16-0084. PubMed PMID: 27259717; PubMed Central PMCID: PMC5025359.
  11. Stine JE, Guo H, Sheng X, Han X, Schointuch MN, Gilliam TP, et al. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer. Oncotarget. 2016;7(1):946-60. Epub 2015/10/28. doi: 10.18632/oncotarget.5834. PubMed PMID: 26503475; PubMed Central PMCID: PMC4808044.
  12. Smith LA, Rossi EL, Bowers LW, Allot EH, Dunlap S, Makowski L, et al. Metabolic and microenvironment changes in the mammary of calorie restricted, normal weight, and obese mice throughout the lifespan. Cancer Res. 2016;76. doi: 10.1158/1538-7445.AM2016-4090. PubMed PMID: ISI:000389969803183.
  13. Seviour EG, Sehgal V, Lu Y, Luo Z, Moss T, Zhang F, et al. Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. Oncogene. 2016;35(6):691-701. Epub 2015/02/03. doi: 10.1038/onc.2014.469. PubMed PMID: 25639871; PubMed Central PMCID: PMC4522411.
  14. Schmid RS, Simon JM, Vitucci M, McNeill RS, Bash RE, Werneke AM, et al. Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. Neuro Oncol. 2016;18(7):962-73. Epub 2016/01/31. doi: 10.1093/neuonc/nov321. PubMed PMID: 26826202; PubMed Central PMCID: PMC4896545.
  15. Sandhu R, Chollet-Hinton L, Kirk EL, Midkiff B, Troester MA. Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma. Hum Pathol. 2016;48:60-8. Epub 2016/01/17. doi: 10.1016/j.humpath.2015.09.031. PubMed PMID: 26772400; PubMed Central PMCID: PMC4727830.
  16. Sambade M, Deal A, Schorzman A, Luft JC, Bowerman C, Chu K, et al. Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT((R)) nanoparticle formulation against non-small-cell lung cancer brain metastases. Nanomedicine (Lond). 2016;11(15):1947-55. Epub 2016/07/28. doi: 10.2217/nnm-2016-0147. PubMed PMID: 27456556; PubMed Central PMCID: PMC4996152.
  17. Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Carey LA, et al. Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer. J Clin Oncol. 2016;34(2):130-8. Epub 2015/11/26. doi: 10.1200/JCO.2015.63.2489. PubMed PMID: 26598755; PubMed Central PMCID: PMC4872005.
  18. Qiu H, Li J, Clark LH, Jackson AL, Zhang L, Guo H, et al. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer. Oncotarget. 2016;7(41):66809-21. Epub 2016/08/31. doi: 10.18632/oncotarget.11631. PubMed PMID: 27572308; PubMed Central PMCID: PMC5341839.
  19. Olesen R, Swanson MD, Kovarova M, Nochi T, Chateau M, Honeycutt JB, et al. ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions. J Clin Invest. 2016;126(3):892-904. Epub 2016/02/09. doi: 10.1172/JCI64212. PubMed PMID: 26854925; PubMed Central PMCID: PMC4767352.
  20. Okolie O, Bago JR, Schmid RS, Irvin DM, Bash RE, Miller CR, et al. Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model. Neuro Oncol. 2016;18(12):1622-33. Epub 2016/06/15. doi: 10.1093/neuonc/now117. PubMed PMID: 27298311; PubMed Central PMCID: PMC5791515.
  21. Nakamura A, Swahari V, Plestant C, Smith I, McCoy E, Smith S, et al. Bcl-xL Is Essential for the Survival and Function of Differentiated Neurons in the Cortex That Control Complex Behaviors. J Neurosci. 2016;36(20):5448-61. Epub 2016/05/20. doi: 10.1523/JNEUROSCI.4247-15.2016. PubMed PMID: 27194326; PubMed Central PMCID: PMC4871982.
  22. Murlidharan G, Crowther A, Reardon RA, Song J, Asokan A. Glymphatic fluid transport controls paravascular clearance of AAV vectors from the brain. JCI insight. 2016;1(14):e88034. Epub 2016/10/05. doi: 10.1172/jci.insight.88034. PubMed PMID: 27699236; PubMed Central PMCID: PMC5033923.
  23. Montgomery ND, Parker JS, Eberhard DA, Patel NM, Weck KE, Sharpless NE, et al. Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing. Appl Immunohistochem Mol Morphol. 2016;24(7):490-5. Epub 2015/09/16. doi: 10.1097/PAI.0000000000000215. PubMed PMID: 26371432; PubMed Central PMCID: PMC4791202.
  24. Montgomery ND, Liomba NG, Kampani C, Krysiak R, Stanley CC, Tomoka T, et al. Accurate Real-Time Diagnosis of Lymphoproliferative Disorders in Malawi Through Clinicopathologic Teleconferences: A Model for Pathology Services in Sub-Saharan Africa. Am J Clin Pathol. 2016;146(4):423-30. Epub 2016/09/07. doi: 10.1093/ajcp/aqw118. PubMed PMID: 27594430; PubMed Central PMCID: PMC5040876.
  25. Miao L, Newby JM, Lin CM, Zhang L, Xu F, Kim WY, et al. The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors. ACS nano. 2016;10(10):9243-58. Epub 2016/09/27. doi: 10.1021/acsnano.6b02776. PubMed PMID: 27666558; PubMed Central PMCID: PMC5515694.
  26. McKee MJ, Keith K, Deal AM, Garrett AL, Wheless AA, Green RL, et al. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience. The oncologist. 2016;21(1):16-20. Epub 2015/12/15. doi: 10.1634/theoncologist.2015-0328. PubMed PMID: 26659221; PubMed Central PMCID: PMC4709216.
  27. Markovic Plese S, Zhang X, Khan T, Zelasky C, Kurtoglu B, Cohen S, et al. IL-11 Induces Th17-Cell Responses in Relapsing Remitting Multiple Sclerosis (RRMS) (P5.338). Neurology. 2016;86(16 Supplement).
  28. Luo C, Miao L, Zhao Y, Musetti S, Wang Y, Shi K, et al. A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA. Biomaterials. 2016;102:239-48. Epub 2016/06/28. doi: 10.1016/j.biomaterials.2016.06.030. PubMed PMID: 27344367; PubMed Central PMCID: PMC5512171.
  29. Lipner MB, Marayati R, Deng Y, Wang X, Raftery L, O’Neil BH, et al. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts. PloS one. 2016;11(1):e0147113. Epub 2016/01/14. doi: 10.1371/journal.pone.0147113. PubMed PMID: 26760500; PubMed Central PMCID: PMC4711922.
  30. Lang N, Sokolsky-Papkov, Shaw, Hwang, Parker, Kabanov, Gershon. ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation. Development. 2016;143(Development 2016 143: 4038-4052; doi: 10.1242/dev.139022 ):4038-52.
  31. Karumuthil-Melethil S, Nagabhushan Kalburgi S, Thompson P, Tropak M, Kaytor MD, Keimel JG, et al. Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease. Hum Gene Ther. 2016;27(7):509-21. Epub 2016/05/21. doi: 10.1089/hum.2016.013. PubMed PMID: 27197548; PubMed Central PMCID: PMC5349231.
  32. Karumuthil-Melethil S, Marshall MS, Heindel C, Jakubauskas B, Bongarzone ER, Gray SJ. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant. J Neurosci Res. 2016;94(11):1138-51. Epub 2016/09/18. doi: 10.1002/jnr.23882. PubMed PMID: 27638599; PubMed Central PMCID: PMC5028109.
  33. Hu P, Li Y, Nikolaishvili-Feinberg N, Scesa G, Bi Y, Pan D, et al. Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe’s disease: Present convictions and future prospects. J Neurosci Res. 2016;94(11):1152-68. Epub 2016/09/18. doi: 10.1002/jnr.23847. PubMed PMID: 27638600; PubMed Central PMCID: PMC5027985.
  34. Guo H, Zhong Y, Jackson AL, Clark LH, Kilgore J, Zhang L, et al. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer. Oncotarget. 2016;7(15):20338-56. Epub 2016/03/10. doi: 10.18632/oncotarget.7934. PubMed PMID: 26959121; PubMed Central PMCID: PMC4991459.
  35. Filgo AJ, Foley JF, Puvanesarajah S, Borde AR, Midkiff BR, Reed CE, et al. Mammary Gland Evaluation in Juvenile Toxicity Studies: Temporal Developmental Patterns in the Male and Female Harlan Sprague-Dawley Rat. Toxicol Pathol. 2016;44(7):1034-58. Epub 2016/09/11. doi: 10.1177/0192623316663864. PubMed PMID: 27613106.
  36. Eason AB, Sin SH, Lin C, Damania B, Park S, Fedoriw Y, et al. Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human. Oncotarget. 2016;7(39):63504-13. Epub 2016/08/28. doi: 10.18632/oncotarget.11531. PubMed PMID: 27566574; PubMed Central PMCID: PMC5325380.
  37. Duncan DL GK, Elmore S, Meyers MO, Civalier C, Ferguson NL, Morgan DR, Gulley ML. Carcinoma-Related Mutation Detected in 23% of Macrodissected Premalignant Gastric Mucosal Lesions.BRAF Mutation Reporting. Journal of Molecular Diagnostics. 2016;18:1014.
  38. Dellon ES, Higgins LL, Beitia R, Rusin S, Woosley JT, Veerappan R, et al. Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016;44(2):189-97. Epub 2016/05/20. doi: 10.1111/apt.13672. PubMed PMID: 27193351; PubMed Central PMCID: PMC4907797.
  39. Crowther AJ, Ocasio JK, Fang F, Meidinger J, Wu J, Deal AM, et al. Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway. Cancer Res. 2016;76(11):3211-23. Epub 2016/05/20. doi: 10.1158/0008-5472.CAN-15-0025. PubMed PMID: 27197166; PubMed Central PMCID: PMC4891232.
  40. Cooley B, Funkhouser W, Monroe D, Ezzell A, Mann DM, Lin FC, et al. Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice. Blood. 2016;128(2):286-92. Epub 2016/04/24. doi: 10.1182/blood-2016-01-696104. PubMed PMID: 27106122; PubMed Central PMCID: PMC5291301.
  41. Camargo MC, Bowlby R, Chu A, Pedamallu CS, Thorsson V, Elmore S, et al. Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2016;19(2):676-81. Epub 2015/06/23. doi: 10.1007/s10120-015-0508-x. PubMed PMID: 26095338; PubMed Central PMCID: PMC4689675.
  42. Byrne JD, Jajja MR, Schorzman AN, Keeler AW, Luft JC, Zamboni WC, et al. Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2016;113(8):2200-5. Epub 2016/02/10. doi: 10.1073/pnas.1600421113. PubMed PMID: 26858448; PubMed Central PMCID: PMC4776454.
  43. Busch EL, Keku TO, Richardson DB, Cohen SM, Eberhard DA, Avery CL, et al. Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease. Clin Exp Metastasis. 2016;33(1):53-62. Epub 2015/10/29. doi: 10.1007/s10585-015-9757-7. PubMed PMID: 26507436; PubMed Central PMCID: PMC4742430.
  44. Brooks SA, Khandani AH, Fielding JR, Lin W, Sills T, Lee Y, et al. Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression. Clin Cancer Res. 2016;22(12):2950-9. Epub 2016/01/21. doi: 10.1158/1078-0432.CCR-15-2115. PubMed PMID: 26787754; PubMed Central PMCID: PMC4911278.
  45. Benamar M, Guessous F, Du K, Corbett P, Obeid J, Gioeli D, et al. Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma. EBioMedicine. 2016;10:85-100. Epub 2016/06/23. doi: 10.1016/j.ebiom.2016.06.023. PubMed PMID: 27333051; PubMed Central PMCID: PMC5006603.
  46. Au KM, Satterlee A, Min Y, Tian X, Kim YS, Caster JM, et al. Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic. Biomaterials. 2016;82:178-93. Epub 2016/01/15. doi: 10.1016/j.biomaterials.2015.12.018. PubMed PMID: 26763733; PubMed Central PMCID: PMC4728024.
  47. Allott EH, Geradts J, Sun X, Cohen SM, Zirpoli GR, Khoury T, et al. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification. Breast Cancer Res. 2016;18(1):68. Epub 2016/06/29. doi: 10.1186/s13058-016-0725-1. PubMed PMID: 27349894; PubMed Central PMCID: PMC4924300.
  48. Allott EH, Cohen SM, Geradts J, Sun X, Khoury T, Bshara W, et al. Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev. 2016;25(3):470-8. Epub 2015/12/30. doi: 10.1158/1055-9965.EPI-15-0874. PubMed PMID: 26711328; PubMed Central PMCID: PMC4779705.


  1. Yuan H, Zhang L, Frank JE, Inscoe CR, Burk LM, Hadsell M, et al. Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study. Radiat Res. 2015;184(3):322-33. Epub 2015/08/26. doi: 10.1667/RR13919.1. PubMed PMID: 26305294; PubMed Central PMCID: PMC4600606.
  2. Wobker SE, Kim LT, Hackman TG, Dodd LG. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma. Cancer cytopathology. 2015;123(9):531-9. Epub 2015/06/17. doi: 10.1002/cncy.21575. PubMed PMID: 26080065.
  3. Williams SE, Garcia I, Crowther AJ, Li S, Stewart A, Liu H, et al. Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in mice. Development. 2015;142(22):3921-32. Epub 2015/10/10. doi: 10.1242/dev.124271. PubMed PMID: 26450969; PubMed Central PMCID: PMC4712878.
  4. Whitehurst CB, Li G, Montgomery SA, Montgomery ND, Su L, Pagano JS. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice. mBio. 2015;6(5):e01574-15. Epub 2015/10/23. doi: 10.1128/mBio.01574-15. PubMed PMID: 26489865; PubMed Central PMCID: PMC4620474.
  5. Speck O, Tang W, Morgan DR, Kuan PF, Meyers MO, Dominguez RL, et al. Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation. Appl Immunohistochem Mol Morphol. 2015;23(9):633-45. Epub 2014/12/18. doi: 10.1097/PAI.0000000000000122. PubMed PMID: 25517873; PubMed Central PMCID: PMC4469637.
  6. Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, et al. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointestinal cancer : targets and therapy. 2015;5:61-71. Epub 2015/04/07. doi: 10.2147/GICTT.S72274. PubMed PMID: 25844041; PubMed Central PMCID: PMC4383253.
  7. Schuler KM, Rambally BS, DiFurio MJ, Sampey BP, Gehrig PA, Makowski L, et al. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer. Cancer medicine. 2015;4(2):161-73. Epub 2014/11/25. doi: 10.1002/cam4.353. PubMed PMID: 25417601; PubMed Central PMCID: PMC4329001.
  8. Roberts MC1 WM, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Troester MA, Carey LA, Wheeler SB. Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing. Breast Cancer Res Treat. 2015;153(1):191-200. Epub 2015 Jul 28. PubMed Central PMCID: PMCPMC4562432.
  9. Qiu HF, Jackson AL, Kilgore JE, Zhong Y, Chang LLY, Gehrig PA, et al. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer. Oncotarget. 2015;6(9):6915-30. doi: DOI 10.18632/oncotarget.3126. PubMed PMID: ISI:000352793800033.
  10. Peck BC, Weiser M, Lee SE, Gipson GR, Iyer VB, Sartor RB, et al. MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn’s Disease and May Have Prognostic Utility. Inflammatory bowel diseases. 2015;21(9):2178-87. Epub 2015/07/15. doi: 10.1097/MIB.0000000000000478. PubMed PMID: 26164662; PubMed Central PMCID: PMC4603665.
  11. Nicol MR, Emerson CW, Prince HM, Nelson JA, Fedoriw Y, Sykes C, et al. Models for predicting effective HIV chemoprevention in women. J Acquir Immune Defic Syndr. 2015;68(4):369-76. Epub 2014/12/17. doi: 10.1097/QAI.0000000000000472. PubMed PMID: 25501616; PubMed Central PMCID: PMC4334725.
  12. Montgomery ND, Graham T, Krysiak R, Kampani C, Liomba NG, Gopal S, et al. Comparison of eosinophil density in staging bone marrow biopsies from Malawi and the United States. Pathol Int. 2015;65(12):671-3. Epub 2015/06/11. doi: 10.1111/pin.12318. PubMed PMID: 26059256; PubMed Central PMCID: PMC4668204.
  13. Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168-78. Epub 2015/09/08. doi: 10.1038/ng.3398. PubMed PMID: 26343385; PubMed Central PMCID: PMC4912058.
  14. McKee MJ, Trembath DG, Deal AM, Keith K, Midkiff BR, Nikolaishvilli-Feinberg N, et al. Histopathological markers at craniotomy and outcome in breast cancer brain metastases. J Clin Oncol. 2015;33(15). doi: DOI 10.1200/jco.2015.33.15_suppl.2027. PubMed PMID: ISI:000358036900486.
  15. Maharshak N, Huh EY, Paiboonrungruang C, Shanahan M, Thurlow L, Herzog J, et al. Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2. Infect Immun. 2015;83(7):2762-70. Epub 2015/04/29. doi: 10.1128/IAI.00425-15. PubMed PMID: 25916983; PubMed Central PMCID: PMC4468563.
  16. Kovarova M, Council OD, Date AA, Long JM, Nochi T, Belshan M, et al. Correction: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. PLoS Pathog. 2015;11(10):e1005170. Epub 2015/10/17. doi: 10.1371/journal.ppat.1005170. PubMed PMID: 26474397; PubMed Central PMCID: PMC4608837.
  17. Kovarova M, Council OD, Date AA, Long JM, Nochi T, Belshan M, et al. Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. PLoS Pathog. 2015;11(8):e1005075. Epub 2015/08/14. doi: 10.1371/journal.ppat.1005075. PubMed PMID: 26271040; PubMed Central PMCID: PMC4536200.
  18. Knight ER, Patel EY, Flowers CA, Crowther AJ, Ting JP, Miller CR, et al. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence. Oncogene. 2015;34(3):394-402. Epub 2014/01/29. doi: 10.1038/onc.2013.577. PubMed PMID: 24469054; PubMed Central PMCID: PMC4520702.
  19. Karginova O, Siegel MB, Van Swearingen AE, Deal AM, Adamo B, Sambade MJ, et al. Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer. Mol Cancer Ther. 2015;14(4):920-30. Epub 2015/04/01. doi: 10.1158/1535-7163.MCT-14-0474. PubMed PMID: 25824335; PubMed Central PMCID: PMC4394032.
  20. Edgerly CH DD, Meyers MO, Elmore S, Gulley ML. Circulating MicroRNA Profiles Reflect Gastric Adenocarcinoma Status. Journal of Molecular Diagnostics. 2015;17(6):829.
  21. Duncan DL TA, Elmore S, Tang W, Greene K, Gulley ML. Inflammation-associated microRNA profiles in gastric adenocarcinoma and in adjacent mucosal tissues. Journal of Molecular Diagnostics. 2015;17(6):823.
  22. Duncan DL GK, Treece AM, Elmore S, Meyers MO, Patel N, Gulley ML. Actionable Mutations and Intrinsic Molecular Subtypes of Gastric Adenocarcinoma Identified in Fixed Tissue. Journal of Molecular Diagnostics. 2015;17(6):829.
  23. Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Shaheen NJ, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28(3):383-90. Epub 2014/09/13. doi: 10.1038/modpathol.2014.110. PubMed PMID: 25216228; PubMed Central PMCID: PMC4344855.
  24. Dellon ES, Rusin S, Gebhart JH, Covey S, Speck O, Woodward K, et al. A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study. Am J Gastroenterol. 2015;110(9):1347-54. Epub 2015/08/26. doi: 10.1038/ajg.2015.239. PubMed PMID: 26303128; PubMed Central PMCID: PMC4586067.
  25. Dellon ES, Rusin S, Gebhart JH, Covey S, Higgins LL, Beitia R, et al. Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol. 2015;110(6):821-7. Epub 2015/03/18. doi: 10.1038/ajg.2015.57. PubMed PMID: 25781367; PubMed Central PMCID: PMC4578703.
  26. Chang EH, Gasim AH, Kerber ML, Patel JB, Glaubiger SA, Falk RJ, et al. Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury. Scientific reports. 2015;5(7695):7695. Epub 2015/01/13. doi: 10.1038/srep07695. PubMed PMID: 25573828; PubMed Central PMCID: PMC4648347.
  27. Casbas-Hernandez P, Sun X, Roman-Perez E, D’Arcy M, Sandhu R, Hishida A, et al. Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev. 2015;24(2):406-14. Epub 2014/12/04. doi: 10.1158/1055-9965.EPI-14-0934. PubMed PMID: 25465802; PubMed Central PMCID: PMC4437571.
  28. Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, et al. IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma. Clin Cancer Res. 2015;21(9):2167-76. Epub 2015/05/03. doi: 10.1158/1078-0432.CCR-14-1826. PubMed PMID: 25934889; PubMed Central PMCID: PMC4418029.
  29. Cannon AR, Owen MK, Guerrero MS, Kerber ML, Goicoechea SM, Hemstreet KC, et al. Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression. Cytoskeleton (Hoboken). 2015;72(8):402-11. Epub 2015/09/04. doi: 10.1002/cm.21239. PubMed PMID: 26333695.
  30. Byrne JD, Jajja MR, O’Neill AT, Bickford LR, Keeler AW, Hyder N, et al. Local iontophoretic administration of cytotoxic therapies to solid tumors. Science translational medicine. 2015;7(273):273ra14. Epub 2015/02/06. doi: 10.1126/scitranslmed.3009951. PubMed PMID: 25653220; PubMed Central PMCID: PMC4545246.
  31. Baker M. Antibody anarchy: A call to order. Nature. 2015;527(7579):545-51. doi: 10.1038/527545a.


  1. Zhou B, Damrauer JS, Bailey ST, Hadzic T, Jeong Y, Clark K, et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. J Clin Invest. 2014;124(2):553-63. Epub 2014/01/18. doi: 10.1172/JCI69804. PubMed PMID: 24435044; PubMed Central PMCID: PMC3904607.
  2. Zhang L YH, Burk LM, Inscoe CR, Hadsell MJ, Chtcheprov P, Lee YZ, Lu J, Chang S, Zhou O. Image-guided microbeam irradiation to brain tumour bearing mice using a carbon nanotube x-ray source array. Phys Med Biol. 2014;59:1283-303. PubMed Central PMCID: PMCPMC4028041.
  3. Wyss AB WM, Avery CL, Herring AH, Bensen JT, Barnholtz-Sloan JS, Funkhouser WK, Olshan AF. Single nucleotide polymorphisms in nucleotide excision repair genes, Cancer Treatment, and the Head and Neck Cancer Survival. Cancer Causes & Control 2014;25:437, 2014. PubMed Central PMCID: PMC PMC4096829.
  4. Wu J HL, Bash R, Cohen S, Ewend M, Wang X, Graham D, Frye S, Earp HS, Miller CR. MerTK as a target in glioblastoma. Abstract. 2014.
  5. Van Swearingen AED SM, Bash R, Golitz B, Santos CM, Darr DB, Parker J, Johnson GL, Miller CR, Anders CK. PI3K and MEK inhibition in intracranial triple negative breast cancer: Efficacy of BKM120 and AZD6244 in preclinical mouse models. Abstract Proceedings of the American Association for Cancer Research. 2014;54:5449A Apr 2014.
  6. Sun X, Sandhu R, Figueroa JD, Gierach GL, Sherman ME, Troester MA. Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expression. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2810-8. Epub 2014/09/25. doi: 10.1158/1055-9965.EPI-14-0507. PubMed PMID: 25249325; PubMed Central PMCID: PMC4278568.
  7. Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, et al. Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models. Clin Cancer Res. 2014;20(23):6083-95. Epub 2014/09/19. doi: 10.1158/1078-0432.CCR-14-0493. PubMed PMID: 25231403; PubMed Central PMCID: PMC4565518.
  8. Simon JM, Hacker KE, Singh D, Brannon AR, Parker JS, Weiser M, et al. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Res. 2014;24(2):241-50. Epub 2013/10/26. doi: 10.1101/gr.158253.113. PubMed PMID: 24158655; PubMed Central PMCID: PMC3912414.
  9. Schuler K, Rambally, BS, DiFurio, MJ, Sampey, S, Gehrig, PA, Makowski, L, Bae-Jump, VL. Biologic and metabolic effects of metformin in a pre-operative window clinical trial for endometrial cancer. Abstract 45th Annual Meeting of the Society of Gynecologic Oncology, March 2014, Tampa, Florida. 2014.
  10. Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. Int J Oncol. 2014;44(2):563-72. Epub 2013/12/04. doi: 10.3892/ijo.2013.2197. PubMed PMID: 24297604; PubMed Central PMCID: PMC3898722.
  11. Rabelo-Gonçalves EMA, Röesler BM, Zeitune JMR. Helicobacter pylori and Liver – Detection of Bacteria in Liver Tissue from Patients with Hepatocellular Carcinoma Using Laser Capture Microdissection Technique (LCM). In: Roesler BM, editor. Trends in Helicobacter pylori Infection. Rijeka: InTech; 2014. p. Ch. 08.
  12. Patel M, Gomez NC, McFadden AW, Moats-Staats BM, Wu S, Rojas A, et al. PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibition. Mol Cancer Res. 2014;12(11):1610-20. Epub 2014/07/06. doi: 10.1158/1541-7786.MCR-14-0006. PubMed PMID: 24994750; PubMed Central PMCID: PMC4233155.
  13. Nikolaishvilli-Feinberg N, Cohen SM, Midkiff B, Zhou Y, Olorvida M, Ibrahim JG, et al. Development of DNA damage response signaling biomarkers using automated, quantitative image analysis. J Histochem Cytochem. 2014;62(3):185-96. Epub 2013/12/07. doi: 10.1369/0022155413516469. PubMed PMID: 24309508; PubMed Central PMCID: PMC3935445.
  14. Nicol MR EC, Nelson JA, Sykes DC, Prince HA, Patterson KB, Kashuba ADM. Tenofovir Diphsophate Concentration Response Relationship for HIV Prevention in Vaginal Tissue. Abstract 2014.
  15. Nicol MR, Fedoriw Y, Mathews M, Prince HM, Patterson KB, Geller E, et al. Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention. J Clin Pharmacol. 2014;54(5):574-83. Epub 2013/12/18. doi: 10.1002/jcph.248. PubMed PMID: 24343710; PubMed Central PMCID: PMC4061289.
  16. Network TCGAR. The Cancer Genome Atlas Research Network. Nature. 2014;507(7492).
  17. Neel NF, Stratford JK, Shinde V, Ecsedy JA, Martin TD, Der CJ, et al. Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation. Mol Cancer Ther. 2014;13(1):122-33. Epub 2013/11/14. doi: 10.1158/1535-7163.MCT-12-1232. PubMed PMID: 24222664; PubMed Central PMCID: PMC3910332.
  18. Moschos SJ, Trembath DG, Snavely AC, Bradler E, Nikolaishvilli-Feinberg N, Midkiff BR, et al. Prognostic significance of PD-L1 expression, angiogenesis, and hypoxia in melanoma brain metastases (MBM): A histopathologic analysis. J Clin Oncol. 2014;32(15). doi: DOI 10.1200/jco.2014.32.15_suppl.9038. PubMed PMID: ISI:000358613204324.
  19. Montgomery N FY. Pathology Consultation on Molecular and Cytogenetic Classification of Intermediate and High Grade B-cell Lymphomas. Am J Clin Pathol. 2014;2014 Mar;141(3):304-317.
  20. McNeill RS VSA, Bash RE, Azam SH, Canoutas DA, Constance BH, Schmid RS, Anders CA, Miller CR. Efficacy of mono and dual PI3K and MAPK inhibition in glioblastoma and triple-negative breast cancer brain metastasis models. J Neuropathol Exp Neurol. 2014;73(6):587 Jun 2014.
  21. McNeill RS SR, Bash RE, Vitucci M, White KK, Werneke AM, Constance BH, Huff B, Miller CR. Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice. Journal of Visualized Experiments. 2014.
  22. Malin D, Strekalova E, Petrovic V, Deal AM, Al Ahmad A, Adamo B, et al. alphaB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res. 2014;20(1):56-67. Epub 2013/10/18. doi: 10.1158/1078-0432.CCR-13-1255. PubMed PMID: 24132917; PubMed Central PMCID: PMC3973485.
  23. Kaufmann WK, Carson CC, Omolo B, Filgo AJ, Sambade MJ, Simpson DA, et al. Mechanisms of chromosomal instability in melanoma. Environ Mol Mutagen. 2014;55(6):457-71. Epub 2014/03/13. doi: 10.1002/em.21859. PubMed PMID: 24616037; PubMed Central PMCID: PMC4128338.
  24. Dellon ES SO, Woodward K, Covey S, Rusin S, Gebhart JH, Woosley JT, Shaheen NJ. Major basic protein, eotaxin-3, and mast cell tryptase staining for diagnosis of eosinophilic esophagitis: A prospective study. Abstract Gastroenterology. 2014;2014; 146 (Suppl 1); S-664 (Mo1828).
  25. Dellon ES CS, Speck O, Woodward K, Rusin S, Gebhart JH, Woosley JT, Shaheen NJ. Immunohistochemical evidence of inflammation is similar in patients with eosinophilic esophagitis and PPI-responsive esophageal eosinophilia: A prospective cohort study. Abstract Gastroenterology. 2014;2014; 146 (Suppl 1); S-15 (Ab 59).
  26. Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Gebhart JH, et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12(12):2015-22. Epub 2014/07/06. doi: 10.1016/j.cgh.2014.06.019. PubMed PMID: 24993367; PubMed Central PMCID: PMC4252508.
  27. Cottrell ML, Kashuba AD. Topical microbicides and HIV prevention in the female genital tract. J Clin Pharmacol. 2014;54(6):603-15. Epub 2014/03/26. doi: 10.1002/jcph.292. PubMed PMID: 24664786; PubMed Central PMCID: PMC4144014.
  28. Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63(2):236-43. Epub 2013/04/13. doi: 10.1136/gutjnl-2013-304531. PubMed PMID: 23580779; PubMed Central PMCID: PMC4384434.
  29. Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, et al. ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma. Eur Urol. 2014;66(1):77-84. Epub 2014/03/13. doi: 10.1016/j.eururo.2014.02.035. PubMed PMID: 24613583; PubMed Central PMCID: PMC4058355.